The year ahead
Over the past few years, we have seen increased interest in the biotechnology industry from large chemical companies, a reflection of its immense promise. We do not see this interest waning in 2014. Although it may increase competition, it also helps draw more resources and attention to the biotechnology sector, helping the sector gain momentum.
In 2014, we aim to unlock more of our potential in emerging markets, which present valuable opportunities in areas such as Household Care where enzyme penetration is relatively low. We will also work for wider adoption of newly launched biosolutions such as Avantec®, Spirizyme® Achieve and Olexa®. It is equally important for us to understand and meet real customer needs in industries that are not growing as much as we would like, for example Food & Beverages.
At the same time, we cannot lose sight of the sustainability of our own operation – a critical part of our business. We did not reach some of our efficiency and diversity targets for 2013, and action has been taken to address this. Sustainability will remain a priority in the coming year as we seek to overcome these challenges.
Our employees play a vital role in our ability to deliver on our expectations and achieve our long-term targets. Therefore, 2014 will see a continuation of our sharpened focus on leadership and employee development. Delivering on our promise of double-digit growth At Novozymes, we believe our biosolutions have the capacity to change the world together with our customers. Only by knowing our customers will we be able to maintain our long-term commitment to innovation and sustainability. And so our journey continues, as we work together to deliver relevant and significant innovation and reach our target of double-digit growth in 2015.
Peder Holk Nielsen
President & CEO